Scope
Reference
C369873
Description
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping
Contract 1. Blood Group Genotyping for Sickle Cell and Thalassaemia
Supplier
Contract value
- £140,671 excluding VAT
- £168,805.20 including VAT
Above the relevant threshold
Award decision date
15 May 2025
Standstill period
- End: 16 December 2025
- 8 working days
Earliest date the contract will be signed
18 December 2025
Contract dates (estimated)
- 19 December 2025 to 31 March 2026
- 3 months, 13 days
Main procurement category
Services
CPV classifications
- 85100000 - Health services
Procedure
Procedure type
Direct award
Supplier
NHSBT
- NHS Organisation Data Service: T1460
500 North Bristol Park, Filton
Bristol
BS34 7QH
United Kingdom
Email: customer.services@nhsbt.nhs.uk
Website: http://www.cromalocksmiths.com
Region: UKK12 - Bath and North East Somerset, North Somerset and South Gloucestershire
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Blood Group Genotyping for Sickle Cell and Thalassaemia
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: england.commercialqueries@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government